Aclidinium bromide improves exercise endurance and decreases exertional dyspnoea in patients with COPD
R. Casaburi, F. Maltais, B. Celli, J. Porszasz, E. Garcia Gil, C. Caracta (Torrance, Boston, Jersey City, United States Of America; , Canada; Barcelona, Spain)
Source: Annual Congress 2010 - Bronchodilators in airways disease
Session: Bronchodilators in airways disease
Session type: Oral Presentation
Number: 5558
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Casaburi, F. Maltais, B. Celli, J. Porszasz, E. Garcia Gil, C. Caracta (Torrance, Boston, Jersey City, United States Of America; , Canada; Barcelona, Spain). Aclidinium bromide improves exercise endurance and decreases exertional dyspnoea in patients with COPD. Eur Respir J 2010; 36: Suppl. 54, 5558
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Effects of aclidinium bromide on exercise endurance, dynamic hyperinflation, physical activity and exertional dyspnoea in patients with moderate to severe COPD Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013
Effectiveness of salmeterol versus ipratropium bromide on exertional dyspnoea in COPD Source: Eur Respir J 2001; 17: 1132-1137 Year: 2001
Effects of oxygen on exertional dyspnea and exercise performance in patients with COPD Source: Annual Congress 2011 - Clinical physiology for clinical problems Year: 2011
Inspiratory capacity (IC) and dyspnea during recovery from symptom-limited exercise in COPD patients treated with tiotropium Source: Eur Respir J 2004; 24: Suppl. 48, 214s Year: 2004
Tiotropium improves walking endurance in COPD Source: Eur Respir J 2012; 39: 265-271 Year: 2012
Effects of arm training on exertional dyspnoea in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 66s Year: 2002
Endurance shuttle walking test: responsiveness to salmeterol in COPD Source: Eur Respir J 2008; 31: 579-584 Year: 2008
Effect of dynamic hyperinflation on exertional dyspnea, exercise performance and quality of life in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 171s Year: 2006
Endurance training decreases exercise-induced dynamic hyperinflation in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 205s Year: 2003
Heliox, dyspnoea and exercise in COPD Source: Eur Respir Rev 2009; 19: 30-38 Year: 2010
The effects of respiratory muscle training on exercise performance and dyspnea in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 67s Year: 2002
Effects of inhaled formoterol on dynamic hyperinflation during and after incremental treadmill exercise in patients with advanced COPD Source: Eur Respir J 2006; 28: Suppl. 50, 172s Year: 2006
Dual bronchodilation with tiotropium/olodaterol further reduces activity-related breathlessness versus tiotropium alone in COPD Source: Eur Respir J, 53 (3) 1802049; 10.1183/13993003.02049-2018 Year: 2019
Effect of pulmonary rehabilitation (PR) on exertional dyspnea and dynamic hyperinflation during six minute walk test in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 209s Year: 2004
Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD Source: Eur Respir J 2009; 33: 771-777 Year: 2009
Six months treatment with salmeterol or ipratropium bromide improves effort tolerance and reduces dyspnoea but does not have any effect on lung function in COPD Source: Eur Respir J 2002; 20: Suppl. 38, 108s Year: 2002
Effect of Heliox and hyperoxia on exercise endurance capacity of patients with severe emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 357s Year: 2001
Cortical activation during constant-work rate cycle exercise in COPD patients: Relation to exertional dyspnea Source: Annual Congress 2010 - State of the art imaging Year: 2010